Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71364 |
Selatogrel
|
||
Selatogrel, also known as ACT-246475, is a reversible, selective, and potent antagonist of the platelet P2Y12 receptor. It therefore acts as a platelet aggregation inhibitor. Selatogrel dose-dependently blocks thrombus formation and displays a wide therapeutic window. | |||
T71362 |
GCC-4401C free base
|
||
GCC-4401C free base is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). |